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Abstract
Motivation: Single nucleotide polymorphisms (SNPs) are the most common type of genetic
variation in humans. However, the factors that affect SNP density are poorly understood. The goal
of this study was to estimate the relative effects of mutability and selection on SNP density in
transcribed regions of human genes. It is important for prediction of the regions that harbor
functional polymorphisms.
Results: We used frequency-validated SNPs resulting from single-nucleotide substitutions. SNPs
were subdivided into five functional categories: (i) 5' untranslated region (UTR) SNPs, (ii) 3' UTR
SNPs, (iii) synonymous SNPs, (iv) SNPs producing conservative missense mutations, and (v) SNPs
producing radical missense mutations. Each of these categories was further subdivided into nine
mutational categories on the basis of the single-nucleotide substitution type. Thus, 45 functional/
mutational categories were analyzed. The relative mutation rate in each mutational category was
estimated on the basis of published data. The proportion of segregating sites (PSSs) for each
functional/mutational category was estimated by dividing the observed number of SNPs by the
number of potential sites in the genome for a given functional/mutational category. By analyzing
each functional group separately, we found significant positive correlations between PSSs and
relative mutation rates (Spearman's correlation coefficient, at least r = 0.96, df = 9, P < 0.001). We
adjusted the PSSs for the mutation rate and found that the functional category had a significant
effect on SNP density (F = 5.9, df = 4, P = 0.001), suggesting that selection affects SNP density in
transcribed regions of the genome. We used analyses of variance and covariance to estimate the
relative effects of selection (functional category) and mutability (relative mutation rate) on the PSSs
and found that approximately 87% of variation in PSS was due to variation in the mutation rate and
approximately 13% was due to selection, suggesting that the probability that a site located in a
transcribed region of a gene is polymorphic mostly depends on the mutability of the site.
Background
Single nucleotide polymorphisms (SNPs) are the most
common type of genetic variation in humans, accounting
for approximately 90% of genetic variations and occurring
every 400 nucleotides on average [1,2]. SNPs are believed
to be the major contributors to interindividual genetic
variation in susceptibility to common human diseases [3-
6]. They are distributed nonrandomly: in some regions,
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their density is high, and in others, it is low [2,7-9].
Because the exonic regions are most likely to carry func-
tional polymorphisms [10], it is important to identify fac-
tors that affect SNP density in exons.
The results of several studies suggest that purifying selec-
tion affects SNP density [11,12]. A comparison of the fix-
ation rates for synonymous, nonsynonymous, and
disease-associated mutations reveals that negative selec-
tion operates against nonsynonymous SNPs [13-15]. Dif-
ferent SNP types are expected to vary in the intensity of
negative selection against them; for example, missense
mutations are expected to be more deleterious than are
silent mutations [16,17].
A few studies have demonstrated that the mutation rate
also can affect SNP density. Schmegner et al. [18] com-
pared SNP densities in G+C-poor and G+C-rich regions
and found a higher SNP density in G+C-rich (i.e., more
mutable) regions, suggesting that SNP density is corre-
lated with mutation rate. Horvath et al. [19] found that G
> A transitions that occur at CpG sites and produce silent
mutations were the most common substitution, suggest-
ing that both mutability and selection play roles in SNP
density in the coding regions of the human genome. How-
ever, the relative effects of these two factors have never
been evaluated on a genome-wide scale. The goal of this
analysis was to estimate the relative effects of mutability
and selection on SNP density. Here we estimate the pro-
portion of segregating (polymorphic) sites in different
regions. The effect of selection is estimated by evaluating
the differences in the proportion of segregating sites
between synonymous, nonsynonymous SNP, as well as 5'
UTR and 3' UTR potential sites. The effect of mutation rate
is estimated by looking at difference in the proportions of
segregating sites for single nucleotide substitutions that
differ by mutation rate (e.g. CpG vs. non-CpG sites).
Methods
SNP data retrieval
We searched the dbSNP database BUILD128 [20-22] to
identify SNPs. The database was accessed February, 2008.
To reduce discovery errors, only validated SNPs (i.e., those
submitted by at least two independent researchers, with at
least one submission validated by a noncomputational
method) were used in this study.
SNPs were stratified into five functional categories: (i) 5'
untranslated region (UTR) SNPs, (ii) 3' UTR SNPs, (iii)
synonymous SNPs, (iv) SNPs producing conservative mis-
sense mutations, and (v) SNPs producing radical missense
substitutions. Missense substitutions were further strati-
fied as radical or conservative according to criteria sug-
gested by Zhang [23]. Briefly, all amino acids were
subdivided into three groups according to their charge:
positive (R, H, K), negative (D, E) and uncharged (A, N, C,
Q, G, I, L, M, F, P, S, T, W, Y, V). The amino acids were fur-
ther subdivided by volume and polarity: special (C), neu-
tral and small (A, G, P, S, T), polar and relatively small (N,
D, Q, E), polar and relatively large (R, H, K), non-polar
and relatively small (I, L, M, V), and non-polar and rela-
tively large (F, W, Y). We considered radical missense
mutations to be those that change amino acid categories
(e.g. R→L) and conservative missense mutations to be
those that do not change amino acid category (e.g. L→V).
Accounting for overlapping genes
Approximately 3% of genes in the human genome overlap
[24], suggesting that some SNPs can be categorized differ-
ently depending on the overlapping gene analyzed. In this
study, we identified 96, or 0.4% of the total number of
SNPs used in the analysis that were located in overlapping
genes. Overlapping SNPs were counted separately for each
overlapping gene. For example, rs3736360 is a radical
missense mutation in the HSPG2 gene and it is a 3' UTR
SNP in the context of the overlapping gene LDLRAD2. We
have conducted analyses both including and excluding
the overlapping SNPs. The results of the analyses were
essentially the same, because of the very low proportion of
excluded SNPs. Because multiple counting of the same
SNPs violates the assumption of independent data points,
we excluded SNPs located in overlapping genes from our
final analyses.
Ancestral and derived alleles
We used data on ancestral and derived alleles from the
dbSNP database [22,25] and the Haplotter database [26].
The requirements that SNPs should be frequency-vali-
dated and that their ancestral state should be known lim-
ited the number of SNPs that could be used in the
analysis. The number of analyzed SNPs, subdivided by
categories, were 1424 for 5' UTR SNPs, 7705 for 3' UTR
SNPs, 6972 for synonymous SNPs, 2567 for conservative
missense mutations, and 3528 for radical missense muta-
tions.
Knowing the ancestral and derived alleles does not tell us
on which DNA strand the substitution has occurred. For
example, for a C/T SNP with ancestral allele C, the ances-
tral pair of nucleotides is C:G and the derived pair of
nucleotides is T:A. Two substitutions are possible in this
case, C > T or G > A. Because it is impossible to tell these
two substitutions apart, we analyzed them jointly. We
separately analyzed substitutions located in CpG sites.
Therefore, the total number of mutational categories ana-
lyzed in this study was nine: (1) nonCpG (C:G > A:T), (2)
nonCpG (C:G > G:C), (3) nonCpG (C:G > T:A), (4) CpG
(C:G > A:T), (5) CpG (C:G > G:C), (6) CpG (C:G > T:A),
(7) (A:T > C:G), (8) (A:T > G:C), and (9) (A:T > T:A). Each
was stratified into five subgroups according to the posi-BMC Genomics 2008, 9:292 http://www.biomedcentral.com/1471-2164/9/292
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tion in the coding region and type of mutation (func-
tional types), resulting in 45 functional/mutational
categories.
Estimating relative mutation rates
To estimate the relative mutation rates, we used mutation
rates obtained by an analysis of processed pseudogenes
[27,28] and direct estimates of mutation rates derived
from an analysis of mutations causing Mendelian diseases
in humans [29]. The results of these studies agree closely:
the Pearson's correlation coefficient between the two esti-
mates is 0.997 (Additional file 1). We assumed that the
mean mutation rate for transversions in nonCpG sites (as
the lowest mutation rate) equals one and computed the
relative mutation rates for other types of SNPs. To esti-
mate the transition rates in CpG sites, we used the ratio of
CpG to nonCpG transitions determined by [28]. We used
a similar method to estimate the relative mutation rates
for CpG and nonCpG C > A, C > G, G > C, and G > T trans-
versions (Table 1). The original data and computations
are presented in Additional file 1. Relative mutation rates
were estimated by assuming that mutation rates for C > A
and G > T transversions are equal one each; then, given
two transversions, it is two for the pair of the transver-
sions. Relative mutation rates for all other substitutions
were computed based on the published estimates of the
mutation rates (see Additional table 2 for details). All
these numbers can be scaled by dividing by two.
Estimating number of potential sites for each functional/
mutational category
A potential site was defined as a single nucleotide substi-
tution (SNS) that would produce a SNP of a specific func-
tional/mutational category. In each nucleotide position,
three SNSs are possible, which correspond with three
potential sites; therefore, the total number of potential
sites per codon is nine.
To estimate the number of potential sites in the coding, 3'
UTR, and 5' UTR regions, we used data from the codon
usage database [30]. We considered nine possible SNSs in
each of 64 codons, yelding a total of 576 wild type-mutant
codon pairs. The pairs were classified as radical nonsyn-
onymous, conservative nonsynonymous, synonymous, or
other (nonsense mutations and mutations that change a
stop codon into an amino acid-encoding codon [elongat-
ing]). These types of codon pairs were not used in this
analysis because corresponding SNPs are relatively rare
and have a high discovery-error rate [31]. To estimate the
numbers of potential sites in these regions, we used data
on the nucleotide content of 5' UTR and 3' UTR regions
[32,33].
The National Center for Biotechnology Information Ent-
rez Gene database (accessed February, 2008) contains
about 23,000 known genes. On the basis of the estimated
mean size of the 5' UTR region, 300 bp, the total number
of potential sites in 5' UTR region is approximately
20,700,000 (23,000 × 300 × 3). Similarly, on the basis of
the estimated size of the 3' UTR region, 770 bp, the total
number of potential sites in the human genome for the 3'
UTR region is 53,130,000.
On the basis of the mean number of exons in a gene (8.8),
the mean size of the exon (145 nucleotides) [34,35], and
the number of known genes ~23,000 (based on the NCBI
Entrez Gene accessed April 30, 2008), the total number of
potential sites in the coding region is 88,044,000.
Estimating number of potential sites in CpGs
Because the mutation rate in CpG dinucleotides is higher
than that in nonCpGs [36-40], they were analyzed sepa-
rately. To estimate the number of potential sites located in
CpGs, we first estimated the proportions of synonymous,
radical, and conservative missense mutations resulting
from SNSs in CpG-containing codons. To account for
CpGs on codon boundaries, we flagged codons that
started with G or ended with C. The proportion of Gs in
the first codon position was 0.31, and the proportion of
Cs among the third positions was 0.30. Assuming a ran-
dom combination of codons, the probability that the first
G nucleotide in a codon would be in a CpG site was 0.30,
and the probability that the last C in a codon would be in
a CpG site was 0.31. The product of these frequencies and
the frequency of the corresponding codon gives the
expected proportion of boundary-located CpGs. To
account for possible violation of the assumption on the
random combination of nucleotides on codon bounda-
ries we compared the expected and the observed number
of CpG on codon boundaries in 56 Seattle genes (see sec-
tion 2.7 for the list of the genes). The expected proportion
of the CpGs on codon boundaries was 0.072 and the
observed 0.023 suggesting that there is the observed
Table 1: Estimated relative mutation rates for pairs of reciprocal 
substitutionsa
Transition/Transversion CpG Substitution pair RMR
Transversion nonCpGb C:G > A:T 2.0
Transversion nonCpGb C:G > G:C 2.0
Transition nonCpG C:G > T:A 7.3
Transversion CpG C:G > A:T 16.0
Transversion CpG C:G > G:C 16.0
Transition CpG C:G > T:A 96.7
Transversion nonCpG A:T > C:G 2.2
Transition nonCpG A:T > G:C 7.3
Transversion nonCpG A:T > T:A 1.8
aOriginal data and computing of relative mutation rates can be found 
in Additional file 1.
bRelative mutation rate is one per transversion C > A or G > T giving 
2 for the C:G > A:T pairBMC Genomics 2008, 9:292 http://www.biomedcentral.com/1471-2164/9/292
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number of CpGs on codon boundaries is ~3.1 times lower
compared to the expected one. We correspondingly
reduced the expected number of the boundary-located
CpGs by the factor 3.1.
SeattleSNPs dataset
The SeattleSNPs project generated SNP data for samples
from both European and African populations [41]. The
database contains sequencing data from genes that are
likely to play a role in common human diseases. The sam-
ple size includes 24 African descent and 23 European
descent subjects. The SNPs were identified by genomic
DNA sequencing and, therefore, provide unbiased repre-
sentation of different types of SNPs in gene regions. We
analyzed the SNPs detected in 56 completely sequenced
genes: AGTRAP, ALOX15, BF, C1QA, CCR2, CSF2, CSF3,
CSF3R, CXCR4, F12, F2RL1, F2RL2, F9, FGA, FGG, FGL2,
FSBP, GP1BA, ICAM4, IFNG, IL10, IL10RA, IL13, IL16,
IL17, IL17B, IL19, IL1B, IL1R1, IL1R2, IL1RN, IL2, IL20,
IL22, IL3, IL4, IL5, IL7R, IL9, IRAK4, KEL, LTA, LTB, NFK-
BIA, PCSK9, PFC, PTGS2, SFTPA2, SFTPC, SFTPD, TCF1,
TNF, VCAM1, VEGF, VTN, ZNF202. We excluded dele-
tions, insertions, and sites with more than 2 alleles from
the analysis. We subdivided all SNPs into 6 functional cat-
egories: (i) 5' untranslated region (UTR) SNPs, (ii) 3' UTR
SNPs, (iii) synonymous SNPs, (iv) SNPs producing con-
servative missense mutations, (v) SNPs producing radical
missense substitutions, and (vi) SNPs in intronic regions.
We included SNPs from the intronic regions because, in
the contrast to dbSNP database, sequencing of the
genomic DNA provides an unbiased estimated of SNPs in
the genic region. The number of potential sites for the
functional/mutational categories was estimated based on
sequence of the 56 SeattleSNPs genes. The sequences 5'
UTR, 3' UTR, intronic and CDS regions were retrieved
using the University of California Santa Cruz (UCSC)
Genome Browser (accessed February 12, 2008). Table 2
shows the sizes and nucleotide compositions of 5' UTR, 3'
UTR, intronic and CDS regions.
Statistical analysis
The proportion of segregating sites (PSSs) was estimated
as the ratio of frequency-validated SNPs of a specific func-
tional/mutational category to the number of potential
sites for that category in the human genome. An analysis
of variance (ANOVA) was used to estimate the effect of
functional categories. An analysis of covariance
(ANCOVA) was used to estimate the effect of the muta-
tion rate on the PSS, controlling for functional category.
All statistical analyses were performed using Statistica
(StatSoft, Inc., Tulsa, OK, USA).
Results
Table 3 shows the estimated absolute numbers of poten-
tial sites. The total number of potential sites for SNPs in
coding regions was estimated to be 9.8 × 107. That is less
than the expected number (1.02 × 108), which was based
on the size of the coding region of the human genome, 34
× 106 nucleotides [35]. This inconsistency occurs because
SNPs that produce nonsense and protein-elongating
mutations were excluded from the analysis. There was
nearly 40-fold variation in the number of potential sites
for the various functional/mutational categories. The
smallest number of potential sites was observed in CpG
dinucleotides in the 3' UTR region; this number was small
simply because the frequency of CpG sites is low in this
region. The maximal number of potential sites was for
nonCpG A:T > C:G substitutions producing radical mis-
sense mutations.
Table 4 shows the observed number of SNPs for the func-
tional/mutational categories. The lowest number of SNPs
was found for C:G > A:T substitution in CpGs producing
conservative missense mutations, and the highest number
was found for A:T > G:C substitutions in the 3' UTR
region. The difference between the lowest and highest
numbers of observed SNPs was 200-fold.
Table 5 shows data on the proportions of segregating sites
(PSSs) in 45 functional/mutational categories. The mean
PSS was approximately 2.8 × 10-6. The highest PSS
detected among the potential sites (4.8 × 10-3) was for
CpG C:G > T:A substitutions in the 3' UTR region; the low-
est (1.4 × 10-5) was for nonCpG A:T > T:A substitutions
producing radical missense mutations. To evaluate how
PSS depends on the relative mutation rate, we estimated
the correlation between PSSs and relative mutation rates.
An analysis conducted within functional categories
yielded Pearson's correlation coefficients that varied from
0.95 (for radical missense mutations) to 0.99 (for SNPs
located in the 3' UTR region). All correlation coefficients
were significant (P < 0.0001). To remove the effect of the
mutation rate, we divided PSSs by the corresponding
mutation rate (Table 6). After this adjustment, the varia-
tion in PSSs was considerably lower. We used ANOVA to
estimate the effect of functional categories on adjusted
PSSs and found that the effect of the functional category
was significant (F = 5.9, df = 4, P = 0.001).
Table 2: The total size and nucleotide compositions of the 
regions from the 56 completely sequenced genes from the 
SeattleSNP database
Region Size (nc) A C G T CpG
5'UTR 7768 1770 2081 1938 1575 404
CDS* 64295 15454 14904 14492 17819 1626
Intronic 557915 150596 116032 121989 163818 5480
3'UTR 47900 13601 9850 9703 14266 480
* coding sequenceBMC Genomics 2008, 9:292 http://www.biomedcentral.com/1471-2164/9/292
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Figure 1A shows the PSSs for nine mutational categories
after the adjustment for the relative mutation rate. We did
not observe significant differences in the adjusted PSSs
between different mutational categories. The lowest aver-
age adjusted PSS was found for radical missense muta-
tions (1.1 × 10-5), and the highest – for 3' UTR region (3.4
× 10-5) (Figure 1B).
To estimate the relative effects of mutation rate and selec-
tion on PSS, we compared a linear model that used both
the mutation rate and functional type as predictors
(model 1) with two others that used only the mutation
rate (model 2) or functional type (model 3) as the predict-
ing variable. Because PSS data were not normally distrib-
uted, we used log transformation to normalize data before
conducting statistical tests (an analysis of nontransformed
data produced similar results, data not shown). We used
ANCOVA for model 1, with PSSs as the outcome variable,
mutation rate as the continuous predictor, and functional
type as the categorical predictor. The whole-model P value
was <0.001, with R2 = 0.53 (F = 8.9, df = 5, P < 0.001).
Model 2 was based on univariate linear regression, with
only mutation rate as the predictor. In this model, R2 was
equal to 0.46 (F = 35.6, df = 1, P < 0.001). Model 3 was
based on the ANOVA, with functional type as the categor-
ical predictor. The R2 for this model was equal to 0.07 (F
= 3.3, df = 4, P<0.03). Summation of R2s for second and
third model gives the expected 53% of variation explained
by model 1 that includes both functional categories and
the relative mutation rate as predictors. These estimates
also demonstrate that 87% [(0.53–0.07)/0.53 = 0.87] of
the variation in the proportion of polymorphic sites was
due to variations in mutation rate and 13% was due to the
effect of functional category that was used to assess the
effect of purifying selection.
Analysis of SeattleSNPs produced results that are similar
to what we have found by the analysis of the dbSNP data.
The total number of SNPs from the Seattle genes was 2474
with 11 SNPs detected in 5' UTR region, 139 SNPs
detected in 3' UTR region, 176 SNPs producing radical,
and 111 SNPs producing conservative missense muta-
tions, 306 synonymous, and 1731 SNPs detected in
intronic regions. The number of SNPs in each of the 45
functional/mutational categories and the estimated
Table 3: Number of potential sites for the 45 functional/mutational categories of SNPs in the human genome
CpG Substitution 5' UTR 3' UTR Rad Cons Syn
nonCpG C:G > A:T 3924000 8778000 8216939 2632167 2456534
nonCpG C:G > G:C 3924000 8778000 7856924 3992722 2291532
nonCpG C:G > T:A 3924000 8778000 5578380 2520193 5495499
CpG C:G > A:T 187200 110880 621000 168400 439500
CpG C:G > G:C 187200 110880 882400 147300 329100
CpG C:G > T:A 187200 110880 520400 293900 538100
nonCpG A:T > C:G 2808000 9424800 10917400 2317667 2610067
nonCpG A:T > G:C 2808000 9424800 8022867 3278733 4780400
nonCpG A:T > T:A 2808000 9424800 9833933 2457067 2523933
20757600 54941040 52450243 17808149 21464665
167421697
Table 4: Observed number of SNPs in each functional/mutation 
category (dbSNP data)
CpG Substitution 5' UTR 3' UTR Rad Cons Syn
nonCpG C:G > A:T 108 531 268 190 187
nonCpG C:G > G:C 139 639 293 365 275
nonCpG C:G > T:A 353 1830 736 502 1954
CpG C:G > A:T 74 65 49 25 155
CpG C:G > G:C 30 56 61 25 67
CpG C:G > T:A 275 1341 926 554 2171
nonCpG A:T > C:G 76 522 261 105 230
nonCpG A:T > G:C 321 2336 796 698 1790
nonCpG A:T > T:A 48 383 138 103 142
Total 99 649 408 222 464
Table 5: Proportion of segregating sites (PSS) in the 45 
functional/mutational categoriesa
CpG Substitution 5' UTR 3' UTR Rad Cons Syns
nonCpG C:G > A:T 2.7 6.1 3.3 7.2 7.6
nonCpG C:G > G:C 3.6 7.3 3.7 9.1 12.0
nonCpG C:G > T:A 9.0 20.8 13.2 19.9 35.6
CpG C:G > A:T 15.8 23.6 3.2 5.9 14.1
CpG C:G > G:C 6.4 20.4 2.8 6.8 8.1
CpG C:G > T:A 58.8 483.8 71.2 75.4 161.4
nonCpG A:T > C:G 2.7 5.5 2.4 4.5 8.8
nonCpG A:T > G:C 11.4 24.8 9.9 21.3 37.5
nonCpG A:T > T:A 1.7 4.1 1.4 4.2 5.6
aAll values × 105BMC Genomics 2008, 9:292 http://www.biomedcentral.com/1471-2164/9/292
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number of potential sites for each category is shown in
Table 7. Figure 2 shows the adjusted proportions of the
segregating sites in the six functional categories of SNPs.
Table 8 shows the adjusted PSSs for the SeatlleSNPs data.
The adjusted PSSs for SNPs in the coding was significantly
lower compared to the 3' UTR and intronic SNPs with P-
values less than 0.01. No difference in the adjusted PSSs
between SNPs in the coding regions and SNPs from the 5'
UTR region were found probably because of the small
sample size: the number of the 5' UTR SNPs was 11.
Discussion
The absolute number of potential sites in the coding
region was estimated on the basis of the frequency of
codons from which a given type of substitution originated
and on the size of the coding region. We further subdi-
vided the functional categories into nine mutation types
on the basis of ancestral and derived alleles. This allowed
us to estimate the effects of mutability (relative mutation
rates) and selection (functional categories) on SNP den-
sity.
We found that the mutation rate was strongly correlated
with PSS. We assumed that different functional categories
are under varying selection pressures; for example, radical
missense mutations are under stronger purifying selection
than are conservative and synonymous mutations. After
adjusting PSSs by mutation rates, we found that func-
tional type had a significant effect on SNP density (P =
0.02), suggesting that selection also plays a role in SNP
density. This result is consistent with those of other stud-
ies [11,14,17,19,42].
To estimate the relative effect of mutability and selection
on the proportion of segregating sites we compared the
model in which both mutability and selection were used
as predictors with the models in which either mutability
or functional category alone were the predicting variables
and found that approximately 87% of PSS variation was
due to variation in the mutation rate and 13% was
explained by the variation in selection intensity (func-
tional categories). The finding that mutation rate rather
than selection plays a major role in SNP density may be
important for the design of association studies. Case-con-
trol association studies are widely used to identify genetic
variants that affect susceptibility to common human dis-
eases [43-46]. An association study usually identifies the
candidate gene (or region) and may require resequencing
of the candidate region to identify functional SNPs. Rese-
quencing of the whole candidate region might be too
expensive; therefore, it is important to identify regions
that are most likely to contain functional polymorphisms.
Our results show that the adjusted PSSs in the 5' UTRs are
similar to, or even lower than, the PSSs for radical mis-
sense mutations.
Analysis of the SeattleSNPs data produced results that sup-
port the idea that 5' UTR regions in the human genome
are subject to strong purifying selection. The adjusted PSS
for 5' UTR SNPs was similar to that for radical missense
mutations and was significantly lower compared to the
intronic and 3' UTR SNPs. In contrast to analysis of the
dbSNP database, we found no differences between synon-
ymous, conservative and radical substitutions. This may
be a result of a much smaller sample size and therefore
insufficient power to detect the differences. It is also pos-
sible that the analysis based on the SeattleSNP data is
biased. The genes for the SeattleSNPs project were selected
based on the two criteria: i) the gene should be function-
ally important with strong evidence for its involvement in
common human diseases; and ii) the gene should be rel-
atively small to allow the direct sequencing. It is possible,
therefore, that the Seattle genes are under a stronger pres-
sure of purifying selection compared to an average gene in
the human genome. This also could explain our finding
that based on the dbSNP data, the ratio of the adjusted
PSS for 3' UTR to the PSS for radical missense mutations
was 3.4, but it was 18.5 based on the SeattleSNPs data.
Limitations of the analysis
Our analysis provides a bird eye view of the control of PSS
in exonic regions of the human genome. Exonic regions
are more likely to be targeted for SNP discovery compared
to the intronic and intergenic regions [47,48], the reason
why we excluded intronic and intergenic regions from our
dbSNP-based analysis. We did not take into account the
fact that intensity of purifying selection can be different
for different genes or different regions in the gene. The rea-
son why we did not analyze more detailed functional cat-
egories is that the density of SNPs in the human genome
is currently not sufficient to conduct the gene-centered
analysis.
Our analysis provides only rough estimates of the effect of
mutability. Though we took into account major sources of
Table 6: Proportion of segregating sites adjusted for relative 
mutation ratesa
CpG Substitution 5' UTR 3' UTR Rad Cons Syn
nonCpG C:G > A:T 1.4 3.0 1.6 3.6 3.8
nonCpG C:G > G:C 1.8 3.6 1.9 4.6 6.0
nonCpG C:G > T:A 1.2 2.9 1.8 2.8 4.9
CpG C:G > A:T 1.0 1.5 0.2 0.4 0.9
CpG C:G > G:C 0.4 1.3 0.2 0.4 0.5
CpG C:G > T:A 0.6 5.0 0.7 0.8 1.7
nonCpG A:T > C:G 1.3 2.6 1.1 2.2 4.2
nonCpG A:T > G:C 1.6 3.4 1.4 3.0 5.2
nonCpG A:T > T:A 0.9 2.3 0.8 2.3 3.1
aAll values × 106BMC Genomics 2008, 9:292 http://www.biomedcentral.com/1471-2164/9/292
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PSSs adjusted for mutation rates (dbSNP data) Figure 1
PSSs adjusted for mutation rates (dbSNP data).A) PSSs (× 106) for the 45 functional/mutational categories. B) Mean 
PSSs among five functional categories.BMC Genomics 2008, 9:292 http://www.biomedcentral.com/1471-2164/9/292
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variation in the mutation rates – transitional or transver-
sional type of substitution and CpG sites [there was
almost 50-fold difference in the relative mutations rate in
our study (Table 1)], it still may be not sufficiently
detailed because there is growing evidence that local dif-
ferences in nucleotide composition can lead to up to 4-
fold differences in the mutation rate [49-51]. We limited
our analysis to the 9 basic mutational categories because
further categorization of sites by mutation rate would
unlikely provide statistically robust estimates.
Ancestral allele information in our analysis was derived
from the comparison of human and chimpanzee
sequences. It is based on the assumption that the out-
group sequence is identical to the ancestral sequence.
Multiple mutations during species divergence may violate
this assumption leading to misidentification of the ances-
tral allele [52]. About 2.6% SNPs in the coding regions of
the human genome may be misidentified [53]. Misidenti-
fication is expected to be highest for sites with the highest
mutation rate and because the derived alleles tend to be
rare, the misidentification will mislabel rare allele as com-
mon leading to inflation of non-neutrality tests, especially
those designed to detect positive selection. It is hard to
estimate the effect of misidentification of ancestral alleles
on the proportion of segregating sites.
PSSs adjusted for mutation rates for 45 functional/mutational categories (SeattleSNP data) Figure 2
PSSs adjusted for mutation rates for 45 functional/mutational categories (SeattleSNP data).
Table 7: Observed number of SNPs in each functional/mutation category (SeattleSNP data)
CpG Substitution 5' UTR 3' UTR Rad Cons Syn Introns
nonCpG C:G > A:T 0 10 15 14 12 113
nonCpG C:G > G:C 0 7 17 16 9 143
nonCpG C:G > T:A 4 33 38 24 69 385
CpG C:G > A:T 0 0 2 1 12 6
CpG C:G > G:C 0 2 7 0 6 20
CpG C:G > T:A 3 23 44 23 123 292
nonCpG A:T > C:G 2 12 11 6 6 125
nonCpG A:T > G:C 2 42 35 26 69 539
nonCpG A:T > T:A 0 10 7 1 0 108
Total 11 139 176 111 306 1731BMC Genomics 2008, 9:292 http://www.biomedcentral.com/1471-2164/9/292
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We estimated the number of the potential sites in CpG
dinucleotides by summarizing the CpGs in codons and
CpGs located on codon boundaries. To our knowledge,
there are only two studies that address the CpG frequen-
cies at codon boundaries. Analysis of hemoglobin genes
[54] demonstrated almost two-fold excess of CpGs at
codon boundaries. On the contrary, a more recent study
of 369 genes (author did not indicate criteria were used
for the gene selection) from tomato demonstrated a more
than two-fold deficit of CpGs compared to the expected
based on the frequency of Cs at third and frequency of Gs
on the first codon position [55]. Analysis of CpGs in Seat-
tle genes demonstrated a 3-fold deficit of the CpG dinu-
cleotides at codon boundaries. After the adjustment for
the deficit of CpG at codon boundaries, the proportion of
CpG dinucleotides was ~0.03 in our analysis, which is
close to the proportion of CpGs – 0.028 estimated based
on the analysis of genes from the Santa Cruz human
genome assembly (hg16) [56].
Conclusion
In conclusion, our results suggest that 5' UTRs are under
purifying selection pressure as strong as that affecting rad-
ical missense mutations. This is consistent with the results
reported by Osada et al. [57], who compared 169 human
and macaque gene sequences and detected a much lower
rate of substitution in 5' UTRs than the rate of synony-
mous substitutions. The authors concluded that SNPs in
5' UTR regions are subject to purifying selection. These
findings and ours suggest that 5' UTRs are important sites
to identify functional disease-associated polymorphisms.
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